TUESDAY, July 15, 2025 (HealthDay News) — Kidney transplant recipients receiving the investigational cellular product MDR-101 achieved functional immune tolerance for more than two years, according to a study published in the July issue of the American Journal of Transplantation. Dixon B. Kaufman, M.D., Ph.D., from the University of Wisconsin School of Medicine and Public […]
The post Cell Therapy MDR-101 Produces Functional Immune Tolerance in Kidney Transplant Recipients first appeared on Physician’s Weekly.
